<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OL</journal-id>
<journal-title-group>
<journal-title>Oncology Letters</journal-title></journal-title-group>
<issn pub-type="ppub">1792-1074</issn>
<issn pub-type="epub">1792-1082</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ol_00000007</article-id>
<article-id pub-id-type="publisher-id">ol-01-01-0041</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Original and infiltrating patterns of prostatic carcinoma</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>FURUBAYASHI</surname><given-names>NOBUKI</given-names></name><xref rid="af1-ol-01-01-0041" ref-type="aff">1</xref><xref ref-type="corresp" rid="c1-ol-01-01-0041"/></contrib>
<contrib contrib-type="author">
<name><surname>NAKAMURA</surname><given-names>MOTONOBU</given-names></name><xref rid="af1-ol-01-01-0041" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>NISHIYAMA</surname><given-names>KENITI</given-names></name><xref rid="af2-ol-01-01-0041" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>HASEGAWA</surname><given-names>YOSHIHIRO</given-names></name><xref rid="af1-ol-01-01-0041" ref-type="aff">1</xref></contrib></contrib-group>
<aff id="af1-ol-01-01-0041">
<label>1</label>Department of Urology, National Kyushu Cancer Center, Fukuoka 811-1395, Japan</aff>
<aff id="af2-ol-01-01-0041">
<label>2</label>Department of Pathology, National Kyushu Cancer Center, Fukuoka 811-1395, Japan</aff>
<author-notes>
<corresp id="c1-ol-01-01-0041"><italic>Correspondence to:</italic> Dr Nobuki Furubayashi, Department of Urology, National Kyushu Cancer Centre, Notame 3-1-1, Minami-ku Fukuoka 811-1395, Japan, E-mail: <email>furubayashi.n@nk-cc.go.jp</email></corresp></author-notes>
<pub-date pub-type="ppub">
<month>1</month>
<year>2010</year></pub-date>
<pub-date pub-type="epub">
<day>01</day>
<month>1</month>
<year>2010</year></pub-date>
<volume>1</volume>
<issue>1</issue>
<fpage>41</fpage>
<lpage>44</lpage>
<history>
<date date-type="received">
<day>08</day>
<month>5</month>
<year>2009</year></date>
<date date-type="accepted">
<day>19</day>
<month>8</month>
<year>2009</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2010, Spandidos Publications</copyright-statement>
<copyright-year>2010</copyright-year></permissions>
<abstract>
<p>In order to demonstrate the original and infiltrating patterns of prostatic carcinoma, the change of histological characteristics associated with increasing total cancer volume was investigated. Tissue specimens from 196 histopathological cases, obtained at the Kyushu Cancer Center, were reviewed in embedded whole-mount antegrade radical prostatectomy specimens with adenocarcinoma. Three groups (&lt;0.5 cm<sup>3</sup>, &#x02264;0.5 cm<sup>3</sup> &lt;1 cm<sup>3</sup> and &#x02265;1 cm<sup>3</sup>) of total cancer volume were identified and a histological study on each group was conducted based on the 2005 International Society of Urological Pathology Consensus Conference on Gleason Grading of Prostatic Carcinoma. With a cancer volume of &lt;0.5 cm<sup>3</sup>, Gleason primary patterns 3 and 4 were observed in 64.4 and 26.7&#x00025; of the tumors, respectively, while Gleason secondary patterns 3 and 4 were observed in 53.3 and 42.2&#x00025;, respectively. The density of the acini was much higher in comparison with that of ambient normal acini. The percentage of acini, including cribriform carcinoma classified as Gleason pattern 3, increased significantly with the increase of cancer volume (p&lt;0.01). The original pattern of the prostatic carcinoma was histologically composed of small acini of Gleason patterns 3 and 4 without forming a cribriform pattern. In addition, prostatic carcinoma infiltrated the surrounding stroma at a very early stage, thus infiltrating not only the stroma but also the preexisting ducts and acini, causing an increased cancer volume.</p></abstract>
<kwd-group>
<kwd>prostatic carcinoma</kwd>
<kwd>low cancer volume</kwd>
<kwd>original pattern</kwd>
<kwd>infiltrating pattern</kwd>
<kwd>Gleason pattern 3 cribriform carcinoma</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>In recent years, more prostatic carcinoma have been detected at an earlier stage because of the widespread use of prostate-specific antigen and transrectal ultrasonography-guided systematic biopsy. Therefore, a low cancer volume has been increasingly observed in radical prostatectomy specimens. Despite this observation, the true natural history of prostatic carcinoma remains largely uncertain (<xref rid="b1-ol-01-01-0041" ref-type="bibr">1</xref>). Subsequently, this study investigated the change of histological characteristics associated with increasing total cancer volume to demonstrate morphological original and infiltrating patterns of prostatic carcinoma which increase total cancer volume.</p></sec>
<sec sec-type="methods">
<title>Materials and methods</title>
<p>Tissue specimens from 248 histopathological cases, obtained between September 2001 and October 2007 at the Kyushu Cancer Center, were reviewed in embedded whole-mount antegrade radical prostatectomy specimens with adenocarcinoma. Fifty-two cases were excluded from the investigation because of past hormonal therapy or incomplete sections. The subjects were Japanese, aged between 47 and 78 years (mean 66.8, median 68) and the value of the prostate-specific antigen ranged from 0.8 to 49.6 ng/ml (mean 10.2, median 7.5). The radical prostatectomy specimens were fixed in 10&#x00025; neutral-buffered formalin for 48&#x02013;96 h. Whole organ prostate specimens were serially sectioned perpendicular to the rectal surface at 5 mm intervals. The most caudal and cephalic sections were cut in sagittal planes at 5 mm intervals to assess the bladder neck and apical margins. The specimens were embedded in paraffin, and the sections were cut into 5 &#x003BC;m slices and then stained with hematoxylin and eosin. The area of each tumor focus was determined by computer planimetry and multiplied by the section thickness. The calculated volume was multiplied by a factor of 1.33 to correct for tissue shrinkage in processing (<xref rid="b2-ol-01-01-0041" ref-type="bibr">2</xref>). In multifocal tumors the volumes of the foci were calculated to determine the radical prostatectomy tumor volume. Three groups (&lt;0.5 cm<sup>3</sup>, &#x02264;0.5 cm<sup>3</sup> &lt;1 cm and &#x02265;1 cm<sup>3</sup>) were identified based on the total cancer volume, and a histological study was conducted on each group. Based on the 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma (<xref rid="b3-ol-01-01-0041" ref-type="bibr">3</xref>), the pathological evaluations were performed by one pathologist. Statistical methods used included the Kruskal-Wallis test.</p></sec>
<sec sec-type="results">
<title>Results</title>
<p>In an evaluation of the Gleason primary pattern, 45 cases with a cancer volume of &lt;0.5 cm<sup>3</sup>, or 64.4&#x00025; of the lesions, exhibited Gleason pattern 3, while Gleason pattern 4 was observed in 26.7&#x00025;; a total of 91.1&#x00025;. When lesions with Gleason pattern 5 were included, the Gleason primary pattern totaled 95.5&#x00025; (<xref rid="tI-ol-01-01-0041" ref-type="table">Table I</xref>). Similarly, secondary Gleason patterns 3 and 4 were observed in 53.3 and 42.2&#x00025; (a total of 95.5&#x00025;) of cases, respectively, for lesions with a cancer volume of &lt;0.5 cm<sup>3</sup>. The Gleason secondary pattern included 97.7&#x00025; when the lesions with Gleason pattern 5 were included (<xref rid="tII-ol-01-01-0041" ref-type="table">Table II</xref>). In addition, no cribriform carcinoma was identified in Gleason pattern 3 in lesions with a cancer volume of &lt;0.5 cm<sup>3</sup> (<xref rid="tIII-ol-01-01-0041" ref-type="table">Table III</xref>). In the group with a cancer volume &lt;0.5 cm<sup>3</sup>, both the Gleason primary and secondary patterns were consistent with a carcinoma with a small size acini. When the density of those acini was compared with that of ambient normal acini, it proved to be much higher (<xref rid="f1-ol-01-01-0041" ref-type="fig">Fig. 1</xref>). With the increase in total cancer volume, Gleason primary pattern 4 and the cribriform carcinoma classified as Gleason pattern 3 increased significantly (p&lt;0.01; <xref rid="tI-ol-01-01-0041" ref-type="table">Tables I</xref> and <xref rid="tIII-ol-01-01-0041" ref-type="table">III</xref>), while the Gleason primary pattern 3 alone decreased (p&lt;0.01; <xref rid="tII-ol-01-01-0041" ref-type="table">Table II</xref>). Over 95&#x00025; of the total cancer volume &#x02265;1 cm<sup>3</sup> contain cribriform carcinoma classified as Gleason pattern 3.</p></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>We aimed to investigate the pattern in which prostatic carcinoma originates and how it invades tissue. Untreated radical prostatectomy specimens archived in this hospital were therefore histologically examined.</p>
<p>Initially the specimens were evaluated based on the 2005 ISUP Consensus Conference on Gleason Grading of Prostatic Carcinoma (<xref rid="b3-ol-01-01-0041" ref-type="bibr">3</xref>). McNeal <italic>et al</italic> reported that evaluation of the whole-tumor histological characteristics may contribute to a better appreciation of the role of histological differentiation compared with other factors in determining the behavior of prostate cancer (<xref rid="b4-ol-01-01-0041" ref-type="bibr">4</xref>). Hence, the total cancer volume was then estimated. The specimens were then classified into three groups based on the total cancer volume.</p>
<p>To demonstrate the original patterns of prostatic carcinoma, lesions with a cancer volume of &lt;0.5 cm<sup>3</sup> were evaluated using the definitions of insignificant cancer described by Stamey <italic>et al</italic> (<xref rid="b5-ol-01-01-0041" ref-type="bibr">5</xref>). Gleason primary patterns 3 and 4 accounted for 91.1&#x00025; of the smaller tumors, while Gleason secondary patterns 3 and 4 were found in 95.5&#x00025; of the lesions. These data indicate that the classification of prostatic carcinoma with a cancer volume of &lt;0.5 cm<sup>3</sup> is predominantly Gleason pattern 3 and 4. In this group, Gleason pattern 3 did not exhibit a cribriform pattern and consisted of assembled acini, which were independent and smaller in size than those characteristic of Gleason patterns 1 or 2. Gleason pattern 4 exhibited independent and ill-defined acini and did not contain large cribriform acini. In other words, the acini of prostate carcinoma with a cancer volume of &lt;0.5 cm<sup>3</sup> consisted mostly of independent acini of a small size. Furthermore, these acini proliferated without disrupting the structure of smooth muscle. The acini were quite dense in comparison to the surrounding non-neoplastic acini (<xref rid="f1-ol-01-01-0041" ref-type="fig">Fig. 1</xref>). Based on these observations, it would appear that small acini of prostatic carcinoma are dense because they invade not only the surrounding acini and small ducts, but also the stroma at a quite early stage. Humphrey reported that the natural history of prostatic carcinoma begins with the invasion of prostatic carcinoma cells in the stroma. Most prostatic carcinomas fail to elicit a stromal response. Subsequently, the malignant acini appear to be embedded within normal-appearing fibromuscular stroma (<xref rid="b6-ol-01-01-0041" ref-type="bibr">6</xref>). These descriptions are consistent with observations in the present study. Prostatic carcinomas originate morphologically in independent small-sized acini. Therefore, prostatic carcinomas are dense in comparison with non-neoplastic acini because of the invasion not only into the surrounding acini and small ducts, but also in the stroma at a relative early stage.</p>
<p>The study also aimed to clarify how the mass of small acini increased by reviewing the changes in the histological features associated with increasing total cancer volume. The primary focus was on the cribriform pattern of the Gleason pattern 3 cribriform carcinoma in particular (<xref rid="f2-ol-01-01-0041" ref-type="fig">Fig. 2</xref>). Cribriform carcinoma classified as Gleason pattern 3 was not observed in any of the 45 cases with a cancer volume of &lt;0.5 cm<sup>3</sup>. McNeal <italic>et al</italic> reported that the histological features of the cribriform grade 3 pattern based on Gleason&#x02019;s original illustrations (<xref rid="b7-ol-01-01-0041" ref-type="bibr">7</xref>&#x02013;<xref rid="b9-ol-01-01-0041" ref-type="bibr">9</xref>) may often represent cancer growing within the lumens of preexisting ducts and acini rather than a pattern of invasive tumor (<xref rid="b10-ol-01-01-0041" ref-type="bibr">10</xref>&#x02013;<xref rid="b12-ol-01-01-0041" ref-type="bibr">12</xref>). Within Gleason&#x02019;s original illustrations, cribriform pattern 3 is depicted as large cribriform acini. However, most of the cribriform patterns in this study were diagnosed to be Gleason pattern 4 (<xref rid="f3-ol-01-01-0041" ref-type="fig">Fig. 3</xref>). The 2005 ISUP reported that it was the consensus that most of the cribriform patterns should be diagnosed as pattern 4, with only rare cribriform lesions satisfying the diagnostic criteria for Gleason pattern 3. Moreover, the criteria used to diagnose Gleason pattern 3 were rounded, well-circumscribed glands of the same size as normal glands (<xref rid="b3-ol-01-01-0041" ref-type="bibr">3</xref>). In the present study, the proportion including cribriform carcinoma classified as Gleason pattern 3 increased significantly with the increase of cancer volume (p&lt;0.01). Thus, &gt;95&#x00025; of the total cancer volume &#x02265;1 cm<sup>3</sup> contain cribriform carcinoma classified as Gleason pattern 3. Based on this observation, the growth of the small acini of prostatic carcinoma within the lumens of preexisting ducts and acini is considered to increase the tumor volume.</p>
<p>It was thought that Gleason pattern 3 cribriform carcinoma expressed an invasion to the terminal acini or small ducts, since they were nearly equal to normal acini in size. In addition, it appeared that Gleason pattern 3 cribriform carcinoma expressed infiltrating preexisting acini and ducts that did not invade peripherally as the lesions were rounded and well-circumscribed. McNeal <italic>et al</italic> noted that with regard to the cribriform pattern, the relationship between total tumor volume and presence of cribriform elements was statistically significant (p&lt;0.001) (<xref rid="b11-ol-01-01-0041" ref-type="bibr">11</xref>). The current results are consistent with those of McNeal <italic>et al</italic>. Therefore, it appears that the cribriform pattern of prostatic carcinoma categorized as Gleason pattern 3 is characteristic of tumors infiltrating the terminal ducts and acini, accelerating the increase of tumor volume. We estimate that the Gleason pattern 4 cribriform carcinoma may express invasion to larger acini and ducts in comparison with the Gleason pattern 3 cribriform carcinoma. As a result, we hypothesize that the Gleason pattern 4 cribriform carcinoma demonstrates the structure of the cribriform pattern which has either a large size or shows marginal irregularity.</p>
<p>In summary, the original pattern of prostatic carcinoma was mainly composed of small acini. In addition, the prostatic carcinoma infiltrated surrounding stroma at quite an early stage. This infiltration caused an increase in the tumor volume in both the stroma and preexisting acini and ducts. However, infiltration of the preexisting ducts and acini is considered to lead to a greater increase in the tumor volume than direct infiltration of the stroma.</p></sec></body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The authors thank Mr. Brian Quinn for linguistic comments and help with the manuscript.</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-ol-01-01-0041"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ekman</surname><given-names>P</given-names></name><name><surname>Adolfsson</surname><given-names>J</given-names></name><name><surname>Gronberg</surname><given-names>H</given-names></name></person-group><source>The natural history of prostate cancer</source><publisher-name>Martin Dunitz</publisher-name><publisher-loc>London</publisher-loc><fpage>1</fpage><lpage>16</lpage><year>1996</year></element-citation></ref>
<ref id="b2-ol-01-01-0041"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elgamal</surname><given-names>AA</given-names></name><name><surname>Van Poppel</surname><given-names>HP</given-names></name><name><surname>Van De Voorde</surname><given-names>WN</given-names></name><name><surname>Van Dorpe</surname><given-names>JA</given-names></name><name><surname>Oyen</surname><given-names>RH</given-names></name><name><surname>Baert</surname><given-names>LV</given-names></name></person-group><article-title>Impalpable invisible stage T1c prostate cancer: characteristics and clinical relevance in 100 radical prostatectomy specimens - a different view</article-title><source>J Urol</source><volume>157</volume><fpage>244</fpage><lpage>250</lpage><year>1997</year></element-citation></ref>
<ref id="b3-ol-01-01-0041"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epstein</surname><given-names>JI</given-names></name><name><surname>Allsbrook</surname><given-names>WC</given-names><suffix>Jr</suffix></name><name><surname>Amin</surname><given-names>MB</given-names></name><name><surname>Egevad</surname><given-names>LL</given-names></name></person-group><collab>the ISUP Grading Committee</collab><article-title>The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma</article-title><source>Am J Surg Pathol</source><volume>29</volume><fpage>1228</fpage><lpage>1242</lpage><year>2005</year></element-citation></ref>
<ref id="b4-ol-01-01-0041"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNeal</surname><given-names>JE</given-names></name><name><surname>Villers</surname><given-names>AA</given-names></name><name><surname>Redwine</surname><given-names>EA</given-names></name><name><surname>Freiha</surname><given-names>FS</given-names></name><name><surname>Stamey</surname><given-names>TA</given-names></name></person-group><article-title>Histologic differentiation, cancer volume and pelvic lymph node metastasis in adenocarcinoma of the prostate</article-title><source>Cancer</source><volume>66</volume><fpage>1225</fpage><lpage>1233</lpage><year>1990</year></element-citation></ref>
<ref id="b5-ol-01-01-0041"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamey</surname><given-names>TA</given-names></name><name><surname>Freiha</surname><given-names>FS</given-names></name><name><surname>McNeal</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer</article-title><source>Cancer</source><volume>71</volume><fpage>933</fpage><lpage>938</lpage><year>1993</year></element-citation></ref>
<ref id="b6-ol-01-01-0041"><label>6</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Humphrey</surname><given-names>PA</given-names></name></person-group><article-title>Natural history and mortality</article-title><source>Prostate Pathology</source><publisher-name>Amer Society of Clinical Pathology</publisher-name><publisher-loc>Chicago</publisher-loc><fpage>241</fpage><lpage>249</lpage><year>2003</year></element-citation></ref>
<ref id="b7-ol-01-01-0041"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailar</surname><given-names>JC</given-names><suffix>III</suffix></name><name><surname>Mellinger</surname><given-names>GT</given-names></name><name><surname>Gleason</surname><given-names>DF</given-names></name></person-group><article-title>Survival rates of patients with prostatic cancer, tumor stage and differentiation: preliminary report</article-title><source>Cancer Chemother Rep</source><volume>50</volume><fpage>129</fpage><lpage>136</lpage><year>1966</year></element-citation></ref>
<ref id="b8-ol-01-01-0041"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gleason</surname><given-names>DF</given-names></name></person-group><article-title>Classification of prostatic carcinomas</article-title><source>Cancer Chemother Rep</source><volume>50</volume><fpage>125</fpage><lpage>128</lpage><year>1966</year></element-citation></ref>
<ref id="b9-ol-01-01-0041"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mellinger</surname><given-names>GT</given-names></name><name><surname>Gleason</surname><given-names>D</given-names></name><name><surname>Bailar</surname><given-names>JC</given-names><suffix>III</suffix></name></person-group><article-title>The histology and prognosis of prostatic cancer</article-title><source>J Urol</source><volume>97</volume><fpage>331</fpage><lpage>337</lpage><year>1967</year></element-citation></ref>
<ref id="b10-ol-01-01-0041"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovi</surname><given-names>J</given-names></name><name><surname>Jackson</surname><given-names>MA</given-names></name><name><surname>Heshmat</surname><given-names>MY</given-names></name></person-group><article-title>Ductal spread in prostatic carcinoma</article-title><source>Cancer</source><volume>56</volume><fpage>1566</fpage><lpage>1573</lpage><year>1985</year></element-citation></ref>
<ref id="b11-ol-01-01-0041"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNeal</surname><given-names>JE</given-names></name><name><surname>Reese</surname><given-names>JH</given-names></name><name><surname>Redwine</surname><given-names>EA</given-names></name><name><surname>Freiha</surname><given-names>FS</given-names></name><name><surname>Stamey</surname><given-names>TA</given-names></name></person-group><article-title>Cribriform adenocarcinoma of the prostate</article-title><source>Cancer</source><volume>58</volume><fpage>1714</fpage><lpage>1719</lpage><year>1986</year></element-citation></ref>
<ref id="b12-ol-01-01-0041"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNeal</surname><given-names>JE</given-names></name><name><surname>Cheryl</surname><given-names>EM</given-names></name></person-group><article-title>Spread of adenocarcinoma within prostatic ducts and acini</article-title><source>Am J Surg Pathol</source><volume>20</volume><fpage>802</fpage><lpage>814</lpage><year>1996</year></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-ol-01-01-0041" position="float">
<label>Figure 1</label>
<caption>
<p>Dense prostatic carcinoma in comparison with non-neoplastic acini.</p></caption>
<graphic xlink:href="OL-01-01-0041-g00.gif"/></fig>
<fig id="f2-ol-01-01-0041" position="float">
<label>Figure 2</label>
<caption>
<p>Gleason grade 3 cribriform carcinoma; rounded, well-circumscribed glands of the same size as normal glands (arrow).</p></caption>
<graphic xlink:href="OL-01-01-0041-g01.gif"/></fig>
<fig id="f3-ol-01-01-0041" position="float">
<label>Figure 3</label>
<caption>
<p>Cribriform carcinoma of Gleason pattern 4. Large cribriform acini and irregularities of the outer border of the cribriform glands are shown.</p></caption>
<graphic xlink:href="OL-01-01-0041-g02.gif"/></fig>
<table-wrap id="tI-ol-01-01-0041" position="float">
<label>Table I</label>
<caption>
<p>Summary of the Gleason primary pattern.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top"/>
<th colspan="4" align="center" valign="top">Gleason primary pattern</th>
<th align="center" valign="top"/></tr>
<tr>
<th align="left" valign="top"/>
<th colspan="4" align="left" valign="top">
<hr/></th>
<th align="center" valign="top"/></tr>
<tr>
<th align="left" valign="top">Cancer volume</th>
<th align="center" valign="top">2</th>
<th align="center" valign="top">3</th>
<th align="center" valign="top">4</th>
<th align="center" valign="top">5</th>
<th align="center" valign="top">Total</th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">&lt;0.5 cm<sup>3</sup></td>
<td align="center" valign="top">2 (4.4&#x00025;)</td>
<td align="center" valign="top">29 (64.4&#x00025;)</td>
<td align="center" valign="top">12 (26.7&#x00025;)</td>
<td align="center" valign="top">2 (4.40&#x00025;)</td>
<td align="right" valign="top">45 (23.0&#x00025;)</td></tr>
<tr>
<td align="left" valign="top">&#x02264;0.5 cm<sup>3</sup>, &lt;1 cm<sup>3</sup></td>
<td align="center" valign="top">0 (0.0&#x00025;)</td>
<td align="center" valign="top">16 (53.3&#x00025;)</td>
<td align="center" valign="top">13 (43.3&#x00025;)</td>
<td align="center" valign="top">1 (3.30&#x00025;)</td>
<td align="right" valign="top">30 (15.3&#x00025;)</td></tr>
<tr>
<td align="left" valign="top">&#x02265;1 cm<sup>3</sup></td>
<td align="center" valign="top">1 (0.8&#x00025;)</td>
<td align="center" valign="top">38 (31.4&#x00025;)</td>
<td align="center" valign="top">65 (53.7&#x00025;)</td>
<td align="center" valign="top">17 (14.00&#x00025;)</td>
<td align="right" valign="top">121 (61.7&#x00025;)</td></tr>
<tr>
<td align="left" valign="top">p-value</td>
<td align="center" valign="top"/>
<td align="center" valign="top">p&lt;0.01</td>
<td align="center" valign="top">p&lt;0.01</td>
<td align="center" valign="top">p&#x0003D;0.08</td>
<td align="right" valign="top"/></tr></tbody></table></table-wrap>
<table-wrap id="tII-ol-01-01-0041" position="float">
<label>Table II</label>
<caption>
<p>Summary of the Gleason secondary pattern.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top"/>
<th colspan="4" align="center" valign="top">Gleason secondary pattern</th>
<th align="center" valign="top"/></tr>
<tr>
<th align="left" valign="top"/>
<th colspan="4" align="left" valign="top">
<hr/></th>
<th align="center" valign="top"/></tr>
<tr>
<th align="left" valign="top">Cancer volume</th>
<th align="center" valign="top">2</th>
<th align="center" valign="top">3</th>
<th align="center" valign="top">4</th>
<th align="center" valign="top">5</th>
<th align="center" valign="top">Total</th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">&lt;0.5 cm<sup>3</sup></td>
<td align="center" valign="top">1 (2.2&#x00025;)</td>
<td align="center" valign="top">24 (53.3&#x00025;)</td>
<td align="center" valign="top">19 (42.2&#x00025;)</td>
<td align="center" valign="top">1 (2.2&#x00025;)</td>
<td align="right" valign="top">45 (23.0&#x00025;)</td></tr>
<tr>
<td align="left" valign="top">&#x02264;0.5 cm<sup>3</sup>, &lt;1 cm<sup>3</sup></td>
<td align="center" valign="top">0 (0.0&#x00025;)</td>
<td align="center" valign="top">11 (36.7&#x00025;)</td>
<td align="center" valign="top">15 (50.0&#x00025;)</td>
<td align="center" valign="top">4 (13.3&#x00025;)</td>
<td align="right" valign="top">30 (15.3&#x00025;)</td></tr>
<tr>
<td align="left" valign="top">&#x02265;1 cm<sup>3</sup></td>
<td align="center" valign="top">1 (0.8&#x00025;)</td>
<td align="center" valign="top">36 (29.8&#x00025;)</td>
<td align="center" valign="top">55 (45.5&#x00025;)</td>
<td align="center" valign="top">29 (24.0&#x00025;)</td>
<td align="right" valign="top">121 (61.7&#x00025;)</td></tr>
<tr>
<td align="left" valign="top">p-value</td>
<td align="center" valign="top"/>
<td align="center" valign="top">p&#x0003D;0.02</td>
<td align="center" valign="top">p&#x0003D;0.08</td>
<td align="center" valign="top">p&lt;0.01</td>
<td align="right" valign="top"/></tr></tbody></table></table-wrap>
<table-wrap id="tIII-ol-01-01-0041" position="float">
<label>Table III</label>
<caption>
<p>Relationship between cribriform carcinoma classified as Gleason pattern 3 and total cancer volume.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Cancer volume</th>
<th align="center" valign="top">GP3CC (&#x0002B;)</th>
<th align="center" valign="top">GP3CC (&#x02212;)</th>
<th align="center" valign="top">Total</th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">&lt;0.5 cm<sup>3</sup></td>
<td align="center" valign="top">0 (0.0&#x00025;)</td>
<td align="center" valign="top">45 (100.0&#x00025;)</td>
<td align="right" valign="top">45</td></tr>
<tr>
<td align="left" valign="top">&#x02264;0.5 cm<sup>3</sup>, &lt;1 cm<sup>3</sup></td>
<td align="center" valign="top">9 (30.0&#x00025;)</td>
<td align="center" valign="top">21 (70.0&#x00025;)</td>
<td align="right" valign="top">30</td></tr>
<tr>
<td align="left" valign="top">&#x02265;1 cm<sup>3</sup></td>
<td align="center" valign="top">116 (95.9&#x00025;)</td>
<td align="center" valign="top">5 (4.1&#x00025;)</td>
<td align="right" valign="top">121</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn1-ol-01-01-0041">
<p>GP3CC, Gleason pattern 3 cribriform carcinoma; p&lt;0.01.</p></fn></table-wrap-foot></table-wrap></floats-group></article>
